Larosso Ltd. – Trademark Portfolio
Entity Type: 99
Larosso Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BADBOY, CHICOLLE, and NUTRADEMIC. The owner is based in Limassol.
Spyrou Kyprianou, 61 SK HOUSE 4003
Limassol , CY
Showing of trademarks Trademarks
Trademark Classifications
Larosso Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Larosso Ltd. have?
Larosso Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Larosso Ltd. file in?
Larosso Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Larosso Ltd.'s most well-known trademarks?
Larosso Ltd.'s registered trademark portfolio includes well-known marks such as BADBOY, CHICOLLE, and NUTRADEMIC. These are among 3 currently registered trademarks in the portfolio.
What is Larosso Ltd.'s trademark registration success rate?
Larosso Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.